<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02933671</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00070686</org_study_id>
    <nct_id>NCT02933671</nct_id>
  </id_info>
  <brief_title>Suprainguinal Fascia Iliaca (SIFI) Block Improves Analgesia Following Total Hip Arthroplasty</brief_title>
  <official_title>Suprainguinal Fascia Iliaca (SIFI) Block Improves Analgesia Following Total Hip Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to learn if using a suprainguinal fascia iliaca (SIFI) injection&#xD;
      technique (also called a &quot;nerve block&quot;) that numbs the nerves going to the side and front of&#xD;
      the upper leg will improve pain control after surgery. The SIFI technique uses a numbing&#xD;
      solution (local anesthetics) that is injected next to nerves in the hip to reduce pain. This&#xD;
      block may affect movement in the leg and make the legs weak. The amount of leg weakness is&#xD;
      not known and assessment of this will be included in the study. Many institutions use the&#xD;
      SIFI block for patients having total hip replacements, with the hope of providing good pain&#xD;
      relief combined with improved mobility after surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study halted prematurely and will not resume; participants are no longer being examined or&#xD;
    receiving any intervention.&#xD;
  </why_stopped>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Actual">March 17, 2020</completion_date>
  <primary_completion_date type="Actual">March 16, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numeric pain score, as measure by numerical rating scale (NRS) 11</measure>
    <time_frame>4 hours postoperatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cumulative opioid consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>IV morphine equivalents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor strength, as measured by dynamometry</measure>
    <time_frame>4 hours postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numeric pain score, as measure by NRS 11</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ambulation, as measured by distanced walked</measure>
    <time_frame>post-op day 0</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Hip Osteoarthritis</condition>
  <condition>Primary Total Hip Arthroplasty</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Suprainguinal Fascia Iliaca (SIFI) block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A nerve block technique using a numbing medication called ropivacaine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The same nerve block technique as above, however using an inactive solution of salt water.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Suprainguinal fascia iliaca (SIFI) block</intervention_name>
    <description>An ultrasound guided nerve block using a medication that numbs the nerve called ropivacaine.</description>
    <arm_group_label>Suprainguinal Fascia Iliaca (SIFI) block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sham block</intervention_name>
    <description>An ultrasound guided nerve block using a medication that does NOT numb the nerve called saline, or salt water.</description>
    <arm_group_label>Sham group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Local anesthetic (numbing drug)</description>
    <arm_group_label>Suprainguinal Fascia Iliaca (SIFI) block</arm_group_label>
    <other_name>Naropin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Salt water placebo</description>
    <arm_group_label>Sham group</arm_group_label>
    <other_name>Salt water</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  English speaking&#xD;
&#xD;
          -  between 18 and 75 years old&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) 1-3 patients undergoing primary total hip&#xD;
             arthroplasty&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ASA 4 or 5&#xD;
&#xD;
          -  revision hip arthroplasty&#xD;
&#xD;
          -  diagnosis of chronic pain&#xD;
&#xD;
          -  daily chronic opioid use (over 3 months of continuous opioid use)&#xD;
&#xD;
          -  inability to communicate pain scores or need for analgesia&#xD;
&#xD;
          -  acute hip fracture&#xD;
&#xD;
          -  Infection at the site of block placement&#xD;
&#xD;
          -  Age under 18 years old or greater than 75 years old&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Intolerance/allergy to local anesthetics&#xD;
&#xD;
          -  Weight &lt;50 kg&#xD;
&#xD;
          -  Suspected, or known addiction to or abuse of illicit drug(s), prescription&#xD;
             medicine(s), or alcohol within the past 2 years.&#xD;
&#xD;
          -  Uncontrolled anxiety, schizophrenia, or other psychiatric disorder that, in the&#xD;
             opinion of the investigator, may interfere with study assessments or compliance&#xD;
&#xD;
          -  Current or historical evidence of any clinically significant disease or condition&#xD;
             that, in the opinion of the investigator, may increase the risk of surgery or&#xD;
             complicate the subject's postoperative course.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Duke University Hospital</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>September 30, 2016</study_first_submitted>
  <study_first_submitted_qc>October 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 14, 2016</study_first_posted>
  <disposition_first_submitted>June 16, 2021</disposition_first_submitted>
  <disposition_first_submitted_qc>June 16, 2021</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">June 18, 2021</disposition_first_posted>
  <last_update_submitted>June 16, 2021</last_update_submitted>
  <last_update_submitted_qc>June 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>suprainguinal fascia iliaca (SIFI)</keyword>
  <keyword>nerve block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis, Hip</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual participant data will not be shared; patients will be deidentified and no personal information or medical records used.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

